William Langridge, PhD Professor, Basic Sciences School of Medicine Member, Biochemistry, SM, Faculty of Graduate Studies

Presentations 

  Research Presentations -- National

• W. Langridge, B. Denes, N. Fodor, V. Krausova T. Timiryasova, D. Henderson, J. Hough, J. Yu, I. Fodor . "Oral delivery of recombinant vaccinia viruses expressing adjuvanted islet autoantigens protects NOD mice from autoimmune diabetes." American Society of Gene Therapy, 8th Annual Meeting,. St. Louis, MO ( 6/2005 )

• W. Langridge. "Plant-based prevention and therapy for Type 1 diabetes." guest lecture. Department of Public Health, Loma Linda University ( 12/2004 )

  Poster Presentation

• The Eleventh Annual Research Symposium, September 10, 2008, Wong Kerlee International Conference Center, "Immunomodulation of the Inhibitor of Apoptosis Protein Survivin", Oludare, Odumosu, Jose Magana, Nathan Wall and William H.R. Langridge, Loma Linda University School of Medicine: Center for Health Disparities and Molecular Medicine, Loma Linda CA. 92350. ( 9/2008 )

• Health Disparities Research Symposium, August 6, 2008, "CTB-Survivin for Cancer Immunotherapy", Jose Luis Magana, Oludare J. Odumosu and William H.R. Langridge, Loma Linda University, Center for Health Disparities and Molecular Medicine, Loma Linda, CA. 92350. ( 8/2008 )

• Health Disparities Research Symposium, August 8, 2007, Center for Health Disparities and Molecular Medicine, Poster: "Castor Oil Plants Synthesize an Immune Modulator that Enhances Autoantigen Mediated Suppression of Diabetes", Karen Rodriguez, Miyako Igari, James E. Carter III, Center for Health Disparities and Molecular Medicine, Loma Linda, CA. 92350. ( 8/2007 )

• B. Denes, V. Krausova, J.Yu, I. Fodor and W. Langridge . "Recombinant vaccinia virus containing a cholera toxin-autoantigen fusion gene protects non obese (NOD)mice against autoimmune diabetes." ." Seventh Annual Research Symposium . Loma Linda University, Loma Linda, CA, 92350 ( 9/2004 )

• Seventh Annual Research Symposium.  Poster Presentation: "Optimal expression of a novel protein produced in E. coli for suppression of type 1 diabetes.", J. Cajigas, J.E.Carter III and W.H.R. Langridge.  Oral presentation of the project to interested faculty, students and visitors, Loma Linda University ( 9/2004 )